首页> 外文期刊>Frontiers in Pharmacology >The Top-100 Highly Cited Original Articles on Drug Therapy for Ventilator-Associated Pneumonia
【24h】

The Top-100 Highly Cited Original Articles on Drug Therapy for Ventilator-Associated Pneumonia

机译:前100个高度引用的原始文章用于呼吸机相关肺炎的药物治疗

获取原文
           

摘要

Background: In recent decades, research on drug therapy for ventilator-associated pneumonia (VAP) remains one of the major hot-spots in the field of critical care medicine, but relevant data are not satisfactory. Our aim was to assess the status and trends of the most cited articles on drug therapy for VAP through bibliometric approaches. Methods: The Institute for Scientific Information (ISI) Web of Science core collection database was searched for the VAP-related articles. The time period for retrieval was from the beginning of the database to September 30, 2018. The top 100 most cited articles were selected to obtain their information on the authors, title, publication, number of citations, author’s affiliations, country, etc. These general information and bibliometric data were collected for analysis. VOSviewer software was used to generate a term co-occurrence graph that visualized a reference pattern for different terms in the 100 articles. Results: The number of citations for the 100 selected articles ranged from 142 to 3,218. These articles were published in 31 different journals. The top three journals in terms of the number of our selected articles they published were “ Critical Care Medicine ” (17 articles), “ American Journal of Respiratory and Critical Care Medicine ” (11 articles) and “ Clinical Infectious Diseases ” (10 articles). The most frequently nominated author was Marin H. Kollef from the University of Washington, and of the top 100 articles, 16 listed his name. These top 100 articles were published after the year of 2000. The most common type of article in the top 100 was an original article (53%). The United States and France were the countries that contributed the most articles to the top 100. Gram-negative bacilli, pseudomonas aeruginosa, antibiotics, risk factors and other terms appeared more frequently, suggesting that attentions on this issue currently focused on the rational application and management of antibiotics. Conclusion: This study analyzed the 100 most cited articles on drug-treated VAP, and provided insights into the historical developments and characteristics of the most cited articles in the field of VAP.
机译:背景:近几十年来,对呼吸机相关肺炎(VAP)的药物治疗研究仍然是关键护理医学领域的主要热点之一,但相关数据并不令人满意。我们的目的是通过圣经测量方法评估对VAP的药物治疗最多的文章的状态和趋势。方法:搜索了与科学核心收集数据库的科学信息学院(ISI)网络相关的VAP相关文章。检索的时间段是从数据库的开始到2018年9月30日。第100个最具引用的文章被选中,以获取有关作者,标题,出版物,引文,作者的附属机构,国家等的信息。这些收集一般信息和伯格计数数据进行分析。 VosViewer软件用于生成术语共同发生图,该图是在100个文章中以不同术语的参考模式可视化。结果:100个选定文章的引用人数从142到3,218。这些文章在31种不同的期刊上发表。在他们发表的所选文章的数量方面的前三个期刊是“关键护理医学”(17篇文章),“美国呼吸系统和关键医学”(11篇文章)和“临床传染病”(10篇) 。最常见的提名作者是华盛顿大学的Marin H. Kollef,其中100篇文章,16篇上市名称。这些前100篇文章在2000年之后发表。前100名中最常见的文章是原始文章(53%)。美国和法国是促使最多的100岁的国家为前100名。克消极的Bacilli,假单胞菌,抗生素,危险因素和其他术语更频繁地出现,这表明对目前专注于理性应用的这个问题的关注抗生素的管理。结论:这项研究分析了100项关于药物处理的VAP的100项文章,并为VAP领域中最引用的物品的历史发展和特征提供了见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号